Emergency Medicine Doctors in Tuolumne, CA Accepting Medicare
1 Emergency Medicine doctors found. Showing 1 - 1
 Dr. Kenneth Keeney Renwick, Jr., MD, MPH, FAAFP Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 18880 Cherry Valley Blvd, Tuolumne, CA 95379 Phone: 209-928-5400 Fax: 209-928-5412 |
News Archive
Research shows gender differences in parents can affect emotional development in children
The act of talking is not an area where ability is usually considered along gender lines. However, a new study published in Springer's journal Sex Roles has found subtle differences between the sexes in their story-relating ability and specifically the act of reminiscing.
New technology developed to rapidly identify compounds for the treatment of heart failure
Research conducted by University of Minnesota scientists, in collaboration with Celladon Corporation, has led to the invention of technology to more rapidly identify compounds for the treatment of heart failure.
Future Science OA accepted for indexing on Database of Open Access Journals
Future Science OA, the inaugural gold open access journal from Future Science Group, has demonstrated its quality and commitment to openness in being accepted for indexing by the Database of Open Access Journals (DOAJ). In addition, it has been awarded the DOAJ seal, which is awarded to those journals that achieve a high level of openness, adhere to best publishing practice and have high publishing standards.
Extolling the safety of childhood vaccinations may only serve to strengthen the positions of those philosophically opposed to them
"Changing attitudes about pediatric vaccination can be challenging," says Dr. Kumanan Wilson, professor of medicine and health policy, management and evaluation at U of T, internal medicine physician at Toronto General Hospital, University Health Network, and lead author of the research.
FDA approves first adjuvant treatment for patients with non-small cell lung cancer
Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.
› Verified 6 days ago